检索结果 - Heidi Greulich

Refine Results
  1. 1
    The Genomics of Lung Adenocarcinoma: Opportunities for Targeted Therapies

    The Genomics of Lung Adenocarcinoma: Opportunities for Targeted Therapies 由 Heidi Greulich

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    An Analysis of Mek1 Signaling in Cell Proliferation and Transformation

    An Analysis of Mek1 Signaling in Cell Proliferation and Transformation 由 Heidi Greulich, Raymond L. Erikson

    出版 1998
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Targeting mutant fibroblast growth factor receptors in cancer

    Targeting mutant fibroblast growth factor receptors in cancer 由 Heidi Greulich, Pamela M. Pollock

    出版 2011
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment

    Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment 由 Grit S. Herter-Sprie, Heidi Greulich, Kwok‐Kin Wong

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Signal Transducer and Activator of Transcription 3 Is Required for the Oncogenic Effects of Non–Small-Cell Lung Cancer–Associated Mutations of the Epidermal Growth Factor Receptor

    Signal Transducer and Activator of Transcription 3 Is Required for the Oncogenic Effects of Non–Small-Cell Lung Cancer–Associated Mutations of the Epidermal Growth Factor Receptor... 由 James V. Alvarez, Heidi Greulich, William R. Sellers, Matthew Meyerson, David A. Frank

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression

    Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression 由 Jingrui Jiang, Heidi Greulich, Pasi A. Jänne, William R. Sellers, Matthew Meyerson, James D. Griffin

    出版 2005
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines

    SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines 由 Francesca Demichelis, Heidi Greulich, Jill A. Macoska, Rameen Beroukhim, William R. Sellers, Levi A. Garraway, Mark A. Rubin

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity

    Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity 由 Cai‐Hong Yun, Titus J. Boggon, Yiqun Li, Michele Sue‐Ann Woo, Heidi Greulich, Matthew Meyerson, Michael J. Eck

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Inhibition of Hsp90 Down-regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel

    Inhibition of Hsp90 Down-regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel 由 Ayana Sawai, Sarat Chandarlapaty, Heidi Greulich, Mithat Gönen, Qing Ye, Carlos L. Arteaga, William R. Sellers, Neal Rosen, David B. Solit

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase.

    The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase. 由 John J. Siekierka, Greg Wiederrecht, Heidi Greulich, David A. Boulton, Shih‐Han Hung, John G. Cryan, Paul J. Hodges, N H Sigal

    出版 1990
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

    The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP 由 Cai‐Hong Yun, Kristen E. Mengwasser, Angela V. Toms, Michele Sue‐Ann Woo, Heidi Greulich, Kwok‐Kin Wong, Matthew Meyerson, Michael J. Eck

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma

    Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma 由 Marcin Imieliński, Heidi Greulich, Bethany Kaplan, Luiz H. Araujo, Joseph M. Amann, Leora Horn, Joan H. Schiller, Miguel A. Villalona‐Calero, Matthew Meyerson, David P. Carbone

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

    Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer 由 Amit Dutt, Alex H. Ramos, Peter S. Hammerman, Craig H. Mermel, Jeonghee Cho, Tanaz Sharifnia, Ajit Chande, Kumiko Tanaka, Nicolas Stransky, Heidi Greulich, Nathanael S. Gray, Matthew Meyerson

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical and Genomic Features

    Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical and Genomic Features 由 Pablo Tamayo, Yoon-Jae Cho, Aviad Tsherniak, Heidi Greulich, Lauren Ambrogio, Netteke Schouten-van Meeteren, Tianni Zhou, Allen Buxton, Marcel Kool, Matthew Meyerson, Scott L. Pomeroy, Jill P. Mesirov

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Loss of the Epigenetic Tumor Suppressor SNF5 Leads to Cancer without Genomic Instability

    Loss of the Epigenetic Tumor Suppressor SNF5 Leads to Cancer without Genomic Instability 由 Elizabeth S. McKenna, Courtney G. Sansam, Yoon-Jae Cho, Heidi Greulich, Julia A. Evans, Christopher S. Thom, Lisa A. Moreau, Jaclyn A. Biegel, Scott L. Pomeroy, Charles W.M. Roberts

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants

    Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants 由 Heidi Greulich, Tzu-Hsiu Chen, Whei Feng, Pasi A. Jänne, James V. Alvarez, Mauro D. Zappaterra, Sara E. Bulmer, David A. Frank, William C. Hahn, William R. Sellers, Matthew Meyerson

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

    BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models 由 D Li, Lauren Ambrogio, Takeshi Shimamura, Shigeto Kubo, Masaya Takahashi, Lucian R. Chirieac, Robert F. Padera, Geoffrey I. Shapiro, Anke Baum, Frank Himmelsbach, Wolfgang J. Rettig, Matthew Meyerson, Flavio Solca, Heidi Greulich, Kah Keng Wong

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Cetuximab Response of Lung Cancer–Derived EGF Receptor Mutants Is Associated with Asymmetric Dimerization

    Cetuximab Response of Lung Cancer–Derived EGF Receptor Mutants Is Associated with Asymmetric Dimerization 由 Jeonghee Cho, Liang Chen, Naveen F. Sangji, Takafumi Okabe, Kimio Yonesaka, Joshua M. Francis, Richard Flavin, William Johnson, Jihyun Kwon, Soyoung Yu, Heidi Greulich, Bruce E. Johnson, Michael J. Eck, Pasi A. Jänne, Kwok‐Kin Wong, Matthew Meyerson

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

    <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy 由 J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J. Kaye, Neal I. Lindeman, Titus J. Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J. Eck, William R. Sellers, Bruce E. Johnson, Matthew Meyerson

    出版 2004
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor

    The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor 由 Susanne Schlisio, Rajappa S. Kenchappa, Liesbeth C.W. Vredeveld, Rani E. George, Rodney A. Stewart, Heidi Greulich, Kristina Shahriari, Nguyen V. Nguyen, Pascal Pigny, Patricia L. M. Dahia, Scott L. Pomeroy, John M. Maris, A. Thomas Look, Matthew Meyerson, Daniel S. Peeper, Bruce Carter, William G. Kaelin

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: